Rituximab-induced autoimmune hepatitis: A case study and literature review-Reference-Cited by-同舟云学术

Rituximab-induced autoimmune hepatitis: A case study and literature review

Published:2020-11 Issue:4 Volume:3 Page:381-386
ISSN:2561-4444
Container-title:Canadian Liver Journal
language:en
Short-container-title:CanLivJ

Author:

Galiatsatos Polymnia¹,Assouline Sarit²,Gologan Adrian³,Hilzenrat Nir¹

Affiliation:

1. Division of Gastroenterology, Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

2. Division of Hematology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

3. Department of Pathology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

Abstract

Rituximab is a monoclonal antibody to CD20, often used to treat B-cell lymphomas and various autoimmune diseases. While there is extensive literature on rituximab-induced liver injury related to hepatitis B reactivation, there have been no reports to date of autoimmune-type idiopathic drug-induced liver injury from this drug. We present a case of necro-inflammatory hepatitis with autoimmune features in a 40-year-old female after receiving a second dose of rituximab for mucosa-associated lymphoid tissue (MALT) lymphoma, with a review of the literature.

Publisher

University of Toronto Press Inc. (UTPress)

Subject

Religious studies,Cultural Studies

Link

https://canlivj.utpjournals.press/doi/pdf/10.3138/canlivj-2020-0009

Reference20 articles.

1. Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

2. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

3. A Case of Rituximab-Induced Hepatitis

4. Drug-induced liver injury: Interactions between drug properties and host factors

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab-Associated Liver Toxicity Without Known Viral Reactivation;Cureus;2024-07-11

2. Evaluation of Metabolism-Dependent Drug Toxicity;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

3. Autoimmune hepatitis;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Liver Pathology Related to Onco-Therapeutic Agents;Surgical Pathology Clinics;2023-09

5. Therapeutic modulation of the liver immune microenvironment;Hepatology;2023-04-17